Literature DB >> 15233563

Is there a role of ghrelin in preventing catabolism?

J A M J L Janssen1, A J van der Lely, S W J Lamberts.   

Abstract

Catabolism is a metabolic process in which muscle and fat cell tissues are broken down in their constituent parts to provide nutrients and energy for the body. Whilst undoubtedly a potent stimulator of GH secretion in pharmacological doses, at present no clear physiological role for ghrelin in the regulation of GH secretion has been identified in man. In addition to its GH-releasing properties, ghrelin stimulates food intake and adipogenesis. The role of ghrelin has been extensively studied in three human models of catabolism: anorexia nervosa, cardiac cachexia and cancer cachexia. In this review we discuss the role of ghrelin in the etiology and treatment of catabolism using these three human models of catabolism. In the presence of clear catabolism in all the three conditions plasma total ghrelin levels are increased, suggesting that ghrelin does not increase food intake and/or anabolism in these circumstances. In addition, it is at present unknown whether administration of additional ghrelin in these conditions may reduce (or attenuate) the development of cachexia. In conclusion, the anabolic effects of ghrelin in man have still to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233563     DOI: 10.1007/BF03351069

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  22 in total

1.  Leptin rapidly lowers food intake and elevates metabolic rates in lean and ob/ob mice.

Authors:  A M Mistry; A G Swick; D R Romsos
Journal:  J Nutr       Date:  1997-10       Impact factor: 4.798

2.  The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.

Authors:  M Korbonits; S A Bustin; M Kojima; S Jordan; E F Adams; D G Lowe; K Kangawa; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

3.  Serum leptin levels, body fat deposition, and weight in females with anorexia or bulimia nervosa.

Authors:  K Mathiak; W Gowin; J Hebebrand; A Ziegler; W F Blum; D Felsenberg; H Lübbert; W Köpp
Journal:  Horm Metab Res       Date:  1999-04       Impact factor: 2.936

4.  Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors.

Authors:  N Nagaya; M Uematsu; M Kojima; Y Date; M Nakazato; H Okumura; H Hosoda; W Shimizu; M Yamagishi; H Oya; H Koh; C Yutani; K Kangawa
Journal:  Circulation       Date:  2001-10-23       Impact factor: 29.690

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines.

Authors:  P L Jeffery; A C Herington; L K Chopin
Journal:  J Endocrinol       Date:  2002-03       Impact factor: 4.286

Review 7.  Ghrelin--not just another stomach hormone.

Authors:  Guiyun Wang; Heung Man Lee; Ella Englander; George H Greeley
Journal:  Regul Pept       Date:  2002-05-15

8.  Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa.

Authors:  Yoshikatsu Nakai; Hiroshi Hosoda; Kazuko Nin; Chizuru Ooya; Hiromi Hayashi; Takashi Akamizu; Kenji Kangawa
Journal:  Eur J Endocrinol       Date:  2003-07       Impact factor: 6.664

9.  Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells.

Authors:  Takeshi Hanada; Koji Toshinai; Naoko Kajimura; Noriko Nara-Ashizawa; Toshihiko Tsukada; Yujiro Hayashi; Kazuhiro Osuye; Kenji Kangawa; Shigeru Matsukura; Masamitsu Nakazato
Journal:  Biochem Biophys Res Commun       Date:  2003-02-07       Impact factor: 3.575

10.  Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness.

Authors:  Mark S Duxbury; Talat Waseem; Hiromichi Ito; Malcolm K Robinson; Michael J Zinner; Stanley W Ashley; Edward E Whang
Journal:  Biochem Biophys Res Commun       Date:  2003-09-19       Impact factor: 3.575

View more
  1 in total

Review 1.  Early satiety in cancer patients: a common and important but underrecognized symptom.

Authors:  Mellar P Davis; Declan Walsh; Ruth Lagman; Tugba Yavuzsen
Journal:  Support Care Cancer       Date:  2006-04-20       Impact factor: 3.603

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.